Mesa Laboratories, Inc.

NASDAQ:MLAB

Hardware, Equipment & Parts

Technology
$137.81 -0.16%

-$0.15 today

Market cap
$774.56M
Beta
0.93
P/E (TTM)
78.3
EPS (TTM)
$1.21
Dividend yield
0.68%
52W Low $55.45High $113.99

Volume 0.07M

Average 0.16M

MLAB Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Mesa Laboratories, Inc.NASDAQ: MLAB

Operating Margin · Q4 FY2026 · quarter ended Mar 2026

Operating margin widens to 4.3%

Operating margin was 4.3% in Q4 FY2026, up 1.9 pp from a year earlier. On a trailing-twelve-month basis it was 7.4%, up 0.7 pp year over year. Over 3 fiscal years it widened by 5.9 pp.

Context

  • Operating margin widened in 2 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 1 analysts of 35.8% for the fiscal year ending Mar 2027, up from 7.4% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
4.3%-7.9 pp QoQ
Last fiscal yearMar 2026
7.4%+0.7 pp YoY
LTMMar 2026
7.4%+0.7 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.9 pp+30.2 pp+28.2 pp
1 year+0.7 pp+28.4 pp+27.7 pp
3 years+5.9 pp——
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2026
7.4%
Year-over-year change
+0.7pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How MLAB compares with its peers on the latest reported figures

  • MLAB's LTM Mar 2026 operating margin of 7.4% is the 8th highest of the 11 companies compared; the peer median is 15.2%.
  • Its year-over-year change of +0.7 pp is the 7th highest of 11, against a peer median of +1.7 pp.
  • Over three fiscal years its change of +5.9 pp compares with a peer median of -4.0 pp.
MLAB Competitors Peer median
Operating Margin for MLAB and competitors
Company Period LTM level YoY 3-year change
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 202646.0% +195.5 pp-68.7 pp
QGENQiagen N.V.LTM Jun 202625.3% +2.4 pp+0.1 pp
AAgilent Technologies, Inc.LTM Jul 202622.2% +1.0 pp-2.3 pp
TECHBio-Techne CorporationLTM Sep 202619.6% +10.6 pp-5.6 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202618.0% -0.5 pp-0.8 pp
RVTYRevvity, Inc.LTM Jul 202612.3% -1.9 pp-11.1 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 20269.1% +0.3 pp-6.8 pp
MLABMesa Laboratories, Inc.LTM Mar 20267.4% +0.7 pp+5.9 pp
TXG10x Genomics, Inc.LTM Sep 2026-11.7% +2.6 pp+15.3 pp
LABStandard BioTools Inc.LTM Mar 2026-91.0% -2.5 pp+9.3 pp
PACBPacific Biosciences of California, Inc.LTM Mar 2026-101.7% +437.7 pp-109.0 pp
Peer median (excluding MLAB) 15.2%+1.7 pp-4.0 pp

Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue184.34M219.08M216.19M240.98M249.13M
Cost of Revenue75.25M85.39M82.94M90.11M90.86M
Gross Profit109.09M133.69M133.25M150.87M158.27M
Gross Margin59.2%61.0%61.6%62.6%63.5%
Research & Development15.77M20.49M19.3M19.52M20.31M
Selling, General & Admin88.62M109.88M111.49M115.02M119.45M
Operating Expenses104.39M130.37M405.33M134.53M139.76M
Depreciation & Amortization25.07M33.13M31.57M24.53M23.27M
EBITDA32.53M37.52M(238.38M)42.35M35.29M
EBITDA Margin17.6%17.1%-110.3%17.6%14.2%
Operating Income4.7M3.32M(272.08M)16.34M18.51M
Operating Margin2.6%1.5%-125.9%6.8%7.4%
Interest Income00000
Interest Expense3.89M4.77M5.7M11.86M10.69M
Other Income / Expenses(1.13M)(3.71M)(3.57M)(10.38M)(6.5M)
Income Before Tax3.57M(389K)(275.65M)5.96M12.01M
Pre-Tax Margin1.9%-0.2%-127.5%2.5%4.8%
Income Tax Expense1.7M(1.32M)(21.4M)7.94M5.3M
Net Income1.87M930K(254.25M)(1.97M)6.71M
Net Margin1.0%0.4%-117.6%-0.8%2.7%
EPS (Basic)0.360.17(47.20)(0.36)1.22
EPS (Diluted)0.350.17(47.20)(0.36)1.21
Weighted Avg Shares5.21M5.32M5.39M5.43M5.51M
Weighted Avg Shares (Diluted)5.34M5.36M5.39M5.43M5.57M

Mesa Laboratories, Inc.

NASDAQ:MLAB

Intrinsic Alpha fair value

Locked

Current Price

$137.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.